Skip to content
healthcare.dev

BUTALBITAL and ACETAMINOPHEN

NDC 70752-148, BUTALBITAL and ACETAMINOPHEN, tablet, from QUAGEN PHARMACEUTICALS LLC.

Product NDC
70752-148
Status
Listed
Labeler
QUAGEN PHARMACEUTICALS LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214291
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70752-148 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUTALBITAL50 mg/1
  • ACETAMINOPHEN325 mg/1

Pharmacologic classes

Barbiturate [EPC]; Barbiturates [CS]

Package NDCNDC-11Package
70752-148-1070752014810100 TABLET in 1 BOTTLE (70752-148-10)
70752-148-1470752014814500 TABLET in 1 BOTTLE (70752-148-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2eb09253-7f59-401e-afbc-70bb9600fedf
  • NADAC price for package 70752014810

    GET /v1/drugs/nadac/70752014810

Use it

Look up 70752-148 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70752-148 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70752-148. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.